Analysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study

Beatriz Nienkotter1, Marcelo Vier Gambetta1, Franciani Rodrigues da Rocha1

  • 1Centro Universitário para o Desenvolvimento do Alto Vale do Itajaí, Núcleo de Pesquisa em Ciências Médicas: Investigações em Saúde, Faculdade de Medicina - Rio do Sul (SC), Brazil.

Revista Da Associacao Medica Brasileira (1992)
|May 24, 2023
PubMed

Insights

Older age and significant pulmonary involvement predict worse outcomes for hospitalized COVID-19 patients. High-flow oxygen therapy indicates a severe prognosis, while corticosteroid treatment showed benefits in managing coronavirus disease 2019.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Clinical Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) poses a significant global health challenge.
  • Understanding the clinical-epidemiological profile of hospitalized patients is crucial for effective management.
  • Tertiary care hospitals play a vital role in managing severe COVID-19 cases.

Purpose of the Study:

  • To analyze the clinical-epidemiological characteristics of COVID-19 patients admitted to a tertiary care hospital.
  • To identify predictors of adverse outcomes and assess survival rates.
  • To evaluate the effectiveness of treatments like corticosteroid therapy.

Main Methods:

  • Observational, retrospective cohort study.
  • Analysis of medical records of 502 patients hospitalized between April 2020 and December 2021.
  • Inclusion of demographic data, comorbidities, laboratory findings, clinical course, and treatment outcomes.

Main Results:

  • The study included 502 patients, with a median age of 56 years; 31.7% were over 65.
  • Common symptoms included dyspnea and cough; frequent comorbidities were obesity, hypertension, and diabetes.
  • Predictors of poor prognosis included age >65, pulmonary involvement >50%, and need for high-flow oxygen therapy. Corticosteroids were widely used (98.4%) with beneficial outcomes.

Conclusions:

  • Age over 65 and extensive pulmonary involvement are significant predictors of worse prognosis in COVID-19.
  • The requirement for high-flow oxygen therapy indicates a more severe disease course.
  • Corticosteroid treatment demonstrated a beneficial effect in the management of hospitalized COVID-19 patients.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
251
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
34
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12